SkinHealth Systems (SKIN) Convertible Debt (2021 - 2026)

SkinHealth Systems (SKIN) has reported Convertible Debt for 6 consecutive years, with $345.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Convertible Debt fell 4.93% year-over-year to $345.2 million in Q2 2026; TTM through Jun 2026 was $345.2 million, a 4.93% decrease from a year earlier, with the FY2025 full-year figure at $364.4 million, down 34.01% from the prior year.
• Convertible Debt was $345.2 million for Q2 2026 at SkinHealth Systems, roughly flat from $344.2 million in the prior quarter.
• Over five years, Convertible Debt peaked at $738.4 million in Q4 2023 and troughed at $344.2 million in Q1 2026.
• A 5-year average of $585.0 million and a median of $609.2 million in 2024 frame the typical range for Convertible Debt.
• Across the five-year window, Convertible Debt climbed 0.58% in 2022 and tumbled 37.75% in 2026, its largest moves.
• Over 5 years, Convertible Debt stood at $734.1 million in 2022, then gained by 0.58% to $738.4 million in 2023, then retreated by 25.21% to $552.2 million in 2024, then plunged by 34.01% to $364.4 million in 2025, then dropped by 5.26% to $345.2 million in 2026.
• The last three Convertible Debt figures came in at $345.2 million (Q2 2026), $344.2 million (Q1 2026), and $364.4 million (Q4 2025), per Business Quant data.